ferric derisomaltose ferric derisomaltose ferric derisomaltose, sold under the brand name monoferric among others, is a medication for the treatment of iron deficiency anemia (ida) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (ndd-ckd). it was approved for use in the united states in january 2020. it is given intravenously. ferric derisomaltoseclinical datatrade namesmonoferric, monoferahfs/drugs.commonographlicense data us dailymed: ferric_derisomaltose routes ofadministrationintravenous (iv)atc codenonelegal statuslegal status au: s4 (prescription only) ca: ℞-only us: ℞-only identifiers iupac name iron(3+);(2s,3r,4r,5r)-6-oxymethyl]oxan-2-yl]oxyhexane-1,2,3,4,5-pentol cas number1345510-43-1pubchem cid86278348drugbankdb15617uniiahu547pi9hkeggd11808chemical and physical dataformulac18h34feo16+3molar mass562.299 g·mol−13d model (jsmol)interactive image smiles c(c1c(c(c(c(o1)occ2c(c(c(c(o2)occ(c(c(c(co)o)o)o)o)o)o)o)o)o)o)o. inchi inchi=1s/c18h34o16.fe/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18;/h5-30h,1-4h2;/q;+3/t5-,6+,7+,8+,9+,10+,11+,12+,13-,14-,15+,16+,17-,18-;/m0./s1key:jtqtxqsgpzrxjf-dojsggeqsa-n